Test Price
2,800 AED✅ Home Collection Available
KCNT1 Gene Epilepsy (Nocturnal Frontal Lobe) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
✔ 99.9% Diagnostic Sensitivity
ISO 9001:2015 Accredited Wet-Lab Processing & Dual-Read NGS Analysis
✔ DHA-Licensed Home Collection (8 AM – 11 PM)
Cold-chain transport, VIP mobile phlebotomy; no hospital visit required
✔ Personalised Post-Test Tele-Consultation
Lina Osama Zaki Quteineh (DHA: 9294403) explains your results & clinical implications
💳 Direct Insurance Billing
WhatsApp +971 54 548 8731 to verify your plan in 2 minutes
Test Overview & Methodology
This definitive NGS-based test analyses the entire coding region of the KCNT1 gene to diagnose autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) and related epileptic encephalopathies. Results guide precision antiepileptic therapy, genetic counselling, and familial risk stratification – delivered within 3–4 weeks on blood, saliva, or extracted DNA.
| Feature | Our KCNT1 NGS Test | Closest Alternative |
|---|---|---|
| Precision | Full gene sequencing (exons + intron flanks) with CNV detection, analytical sensitivity >99.9% | Limited single-exon deletion/duplication assays by MLPA – may miss deep intronic or novel variants |
| Methodology | NGS (Next-Generation Sequencing) with orthogonal Sanger confirmation; ISO 9001:2015 accredited | Targeted mutation panels or single-site testing without comprehensive coverage of all KCNT1 pathogenic hotspots |
| Turnaround | 3–4 weeks, inclusive of clinical report & tele-counselling | 4–6 weeks, often without integrated post-test clinician review |
Physician Insight & Safety Protocols
“As a consultant medical geneticist with extensive experience in inherited epilepsies, I understand the anxiety awaiting a definitive diagnosis. This test provides the molecular clarity needed to distinguish KCNT1-related disorders from other sleep-related paroxysmal events, but a normal result does not exclude all genetic causes. I interpret every result within the full clinical picture, including EEG and seizure semiology, to ensure no family navigates this journey alone.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠ MEDICATION SAFETY NOTICE
Do not discontinue or modify any prescribed antiepileptic drug without direct consultation with your treating neurologist. Abrupt cessation may provoke prolonged seizures or status epilepticus.
Exclusion Criteria & Emergency Red Flags
- Neonates & Unwell Infants: Home collection not recommended for infants with unstable vital signs; hospital-based sampling is mandated under UAE regulations for minors in acute distress.
- Suspected Non-Accidental Injury: Any sign of trauma requiring forensic evaluation must be addressed in a hospital emergency department before genetic testing.
- Current Status Epilepticus: Active prolonged seizure is a medical emergency; call 998 immediately. Genetic sample collection should be deferred until the patient is stable.
- Severe Bleeding Disorder: Patients with known haemophilia or on high-dose anticoagulants require a risk assessment by a specialist before phlebotomy.
Patient FAQ & Clinical Guidance
1. What does the KCNT1 gene test detect and how accurate is it for nocturnal frontal lobe epilepsy?
This test detects single nucleotide variants, small insertions/deletions, and copy number changes across the entire KCNT1 gene with a diagnostic sensitivity exceeding 99.9% for all reported pathogenic mutations.
2. Can my child undergo this at home and is it legally compliant in the UAE?
Yes, our DHA-licensed mobile phlebotomists perform paediatric home collections under strict consent protocols compliant with Federal Decree-Law No. 4 of 2016 on Medical Liability (parental authorisation documented via video verification and e-signature).
3. How long does it take to receive results and will a doctor explain them to me?
The standard reporting time is 3–4 weeks from sample arrival; each report includes a scheduled telephone consultation with Lina Osama Zaki Quteineh who translates genetic findings into personalised treatment guidance.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access-controlled, and processed exclusively within the UAE. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | KCNT1 Gene Epilepsy (Nocturnal Frontal Lobe) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood, saliva, or extracted DNA; VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) with orthogonal Sanger confirmation; ISO 9001:2015 accredited |
| ICD-10-CM Code | G40.0 (Localization-related idiopathic epilepsy) |
| LOINC Code | 92747-3 (Epilepsy next generation sequencing panel) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians